Literature DB >> 3322358

The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon.

M H Rustin1, N E Almond, J A Beacham, R J Brooks, D P Jones, E D Cooke, P M Dowd.   

Abstract

Fifteen patients with primary Raynaud's phenomenon received captopril 25 mg or placebo, three times daily for 6 weeks, in a randomized double-blind cross-over study. Compared with placebo, captopril produced a significant improvement in cutaneous blood flow but did not alter the frequency or severity of attacks of Raynaud's phenomenon.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3322358     DOI： 10.1111/j.1365-2133.1987.tb07356.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  12 in total

Review 1.  The current treatment of scleroderma.

Authors:  G F Oliver; R K Winkelmann
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

Review 2.  [Medicinal vasoactive therapy of microcirculation disorders in rheumatoid arthritis].

Authors:  G Riemekasten; H Schulze-Koops
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372

Review 3.  Raynaud's syndrome.

Authors:  E D Cooke; A N Nicolaides
Journal:  BMJ       Date:  1990-03-03

Review 4.  [Raynaud phenomenon in dermatology : Part 2: therapy].

Authors:  C Sunderkötter; G Riemekasten
Journal:  Hautarzt       Date:  2006-10       Impact factor: 0.751

Review 5.  [Evidence-based therapy of Raynaud's syndrome].

Authors:  M Distler; J Distler; A Ciurea; D Kyburz; U Müller-Ladner; K Reich; O Distler
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

6.  Subjective and objective assessment of enalapril in primary Raynaud's phenomenon.

Authors:  V F Challenor; D G Waller; R A Hayward; M J Griffin; O S Roath
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

Review 7.  The diagnosis and treatment of Raynaud's phenomenon: a practical approach.

Authors:  Janet E Pope
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  A comparison of the effects of captopril and enalapril on skin responses to intradermal bradykinin and skin blood flow in the human forearm.

Authors:  T C Li Kam Wa; E D Cooke; P Turner
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335

9.  Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management.

Authors:  Zsuzsanna H McMahan; Fredrick M Wigley
Journal:  Int J Clin Rheumtol       Date:  2010

Review 10.  Angiotensin converting enzyme inhibitors in Raynaud's phenomenon.

Authors:  V F Challenor
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.